Friedreich's ataxia: clinical features, pathogenesis and management

Area of Science:

• Neurogenetics
• Molecular Medicine

Background:

• Friedreich's ataxia is the most prevalent inherited ataxia.
• Recent advances have improved understanding of the disease's pathogenesis.

Purpose of the Study:

• To review current understanding and therapeutic targets for Friedreich's ataxia.
• To identify areas for future research and clinical development.

Main Methods:

• Comprehensive literature search of PubMed.
• Inclusion of relevant published papers known to the authors.

Main Results:

• Genetic and epigenetic mechanisms offer novel therapeutic targets.
• Effective disease-modifying agents are still under investigation.
• Debate exists on whether to increase frataxin levels or address metabolic consequences.

Conclusions:

• Current management is symptomatic, relying on multidisciplinary teams.
• Phase II trial results for frataxin gene silencing agents require validation in Phase III trials.
• Establishing therapeutic potential necessitates large, placebo-controlled Phase III studies.